Literature DB >> 2963658

The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study.

J V Anderson1, P W Woodruff, S R Bloom.   

Abstract

Eleven patients with acute congestive heart failure were studied during treatment with a loop diuretic. Plasma concentrations of atrial natriuretic peptide were considerably increased before treatment and with successful treatment returned progressively towards normal values. There was a statistically significant correlation between plasma atrial natriuretic peptide concentration and both jugular venous pressure and change of body weight. These results support the hypothesis that atrial distension is an important stimulus to atrial natriuretic peptide release. Furthermore, the close relation between plasma concentrations of atrial natriuretic peptide and clinical improvement in these patients suggests that measurement of plasma atrial natriuretic peptide concentration could provide a clinically useful and non-invasive method of monitoring the response to treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2963658      PMCID: PMC1276986          DOI: 10.1136/hrt.59.2.207

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  19 in total

Review 1.  Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.

Authors:  J H Laragh
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

2.  Renin relationships in congestive cardiac failure, treated and untreated.

Authors:  J J Brown; D L Davies; V W Johnson; A F Lever; J I Robertson
Journal:  Am Heart J       Date:  1970-09       Impact factor: 4.749

3.  Atrial natriuretic peptide concentrations in blood from right atrium in patient with severe right heart failure.

Authors:  E Hartter; M Weissel; H K Stummvoll; W Woloszczuk; C Punzengruber; B Ludvik
Journal:  Lancet       Date:  1985-07-13       Impact factor: 79.321

4.  Physiology: cardiac peptides and the control of sodium excretion.

Authors:  G A Sagnella; G A MacGregor
Journal:  Nature       Date:  1984 Jun 21-27       Impact factor: 49.962

5.  Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers.

Authors:  I Tikkanen; F Fyhrquist; K Metsärinne; R Leidenius
Journal:  Lancet       Date:  1985-07-13       Impact factor: 79.321

6.  Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma.

Authors:  G A Sagnella; N D Markandu; A C Shore; G A MacGregor
Journal:  Lancet       Date:  1985-11-30       Impact factor: 79.321

Review 7.  Neurohumoral control mechanisms in congestive heart failure.

Authors:  J N Cohn; T B Levine; G S Francis; S Goldsmith
Journal:  Am Heart J       Date:  1981-09       Impact factor: 4.749

8.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

9.  Bedside haemodynamic monitoring: experience in a general hospital.

Authors:  J Bayliss; M Norell; A Ryan; M Thurston; G C Sutton
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-16

10.  Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure.

Authors:  J V Anderson; A E Raine; A Proudler; S R Bloom
Journal:  J Endocrinol       Date:  1986-08       Impact factor: 4.286

View more
  6 in total

1.  Atrial natriuretic peptide and water and electrolyte transport in the human jejunum.

Authors:  J Brunner; R Lübcke; G O Barbezat; T G Yandle; E A Espiner
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

2.  Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.

Authors:  M Lough; J Cleland; J Langan; A Cowley; A Wade
Journal:  BMJ       Date:  1998-11-14

3.  Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide.

Authors:  Uzoma N Ibebuogu; Inna P Gladysheva; Aiilyan K Houng; Guy L Reed
Journal:  Circ Heart Fail       Date:  2011-01-07       Impact factor: 8.790

Review 4.  Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.

Authors:  A C Tan; F G Russel; T Thien; T J Benraad
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

5.  Atrial natriuretic peptide, aldosterone, and plasma renin activity in peripartum heart failure.

Authors:  C O Adesanya; F I Anjorin; I A Sada; E H Parry; G A Sagnella; G A MacGregor
Journal:  Br Heart J       Date:  1991-03

6.  Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase.

Authors:  P A Phillips; J Sasadeus; G P Hodsman; J Horowitz; A Saltups; C I Johnston
Journal:  Br Heart J       Date:  1989-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.